======= HSD17B8 ======= == Gene Information == * **Official Symbol**: HSD17B8 * **Official Name**: hydroxysteroid 17-beta dehydrogenase 8 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7923|7923]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q92506|Q92506]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HSD17B8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HSD17B8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601417|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: NAD-dependent 17-beta-hydroxysteroid dehydrogenase with highest activity towards estradiol. Has very low activity towards testosterone (PubMed:17978863). The heterotetramer with CBR4 has NADH-dependent 3-ketoacyl-acyl carrier protein reductase activity, and thereby plays a role in mitochondrial fatty acid biosynthesis (PubMed:19571038, PubMed:25203508). Within the heterotetramer, HSD17B8 binds NADH; CBR4 binds NADPD (PubMed:25203508). {ECO:0000269|PubMed:17978863, ECO:0000269|PubMed:19571038, ECO:0000269|PubMed:25203508}. |KR| |adh short| |3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity| |NADH binding| |testosterone dehydrogenase (NAD+) activity| |mitochondrial envelope| |3-hydroxyacyl-CoA dehydrogenase activity| |estradiol 17-beta-dehydrogenase activity| |estrogen biosynthetic process| |oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor| |androgen metabolic process| |estrogen metabolic process| |fatty-acyl-CoA biosynthetic process| |protein heterotetramerization| |fatty-acyl-CoA metabolic process| |thioester biosynthetic process| |acyl-CoA biosynthetic process| |steroid hormone biosynthetic process| |ribonucleoside bisphosphate biosynthetic process| |nucleoside bisphosphate biosynthetic process| |purine nucleoside bisphosphate biosynthetic process| |hormone biosynthetic process| |fatty acid derivative biosynthetic process| |thioester metabolic process| |acyl-CoA metabolic process| |protein heterooligomerization| |fatty acid biosynthetic process| |cellular hormone metabolic process| |steroid biosynthetic process| |nucleoside bisphosphate metabolic process| |purine nucleoside bisphosphate metabolic process| |ribonucleoside bisphosphate metabolic process| |coenzyme biosynthetic process| |purine ribonucleotide biosynthetic process| |protein tetramerization| |purine nucleotide biosynthetic process| |ribonucleotide biosynthetic process| |fatty acid derivative metabolic process| |ribose phosphate biosynthetic process| |purine-containing compound biosynthetic process| |sulfur compound biosynthetic process| |monocarboxylic acid biosynthetic process| |hormone metabolic process| |cofactor biosynthetic process| |nucleotide biosynthetic process| |nucleoside phosphate biosynthetic process| |coenzyme metabolic process| |steroid metabolic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |purine ribonucleotide metabolic process| |fatty acid metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |sulfur compound metabolic process| |purine-containing compound metabolic process| |mitochondrial matrix| |cofactor metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |protein complex oligomerization| |amide biosynthetic process| |monocarboxylic acid metabolic process| |regulation of hormone levels| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |lipid biosynthetic process| |small molecule biosynthetic process| |carbohydrate derivative biosynthetic process| |cellular amide metabolic process| |organophosphate metabolic process| |carboxylic acid metabolic process| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |carbohydrate derivative metabolic process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |lipid metabolic process| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |protein-containing complex assembly| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|1.78| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|1.81| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18210 * **Expression level (log2 read counts)**: 2.7 {{:chemogenomics:nalm6 dist.png?nolink |}}